Analyst Ratings for Avid Bioservices (CDMO) [Buys]
CDMO Rating Summary
CDMO Price Target Summary
- Highest: $16.00 (Craig-Hallum)
- Lowest: $7.00 (RBC Capital)
- Average: $12.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.25 (+81.2%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
Avg. $ Target:
$12.25 (+81.2%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2023 | KeyBanc » Updated 12/8/2023 |
Paul Knight | Upgrade | Overweight (Sector Weight) |
14.00 (20.00) |
13.95 (6.76) |
-51.54% | Details |
| 3/17/2021 | RBC Capital » Updated 12/8/2023 |
Sean Dodge | New Coverage | Outperform (N/A) |
7.00 (15.00) |
17.68 (6.76) |
-61.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
